Screening for Fibrosis in MASLD

What is the current role of imaging in screening for fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)? Gastrointestinal Imaging Senior Editor Federica Vernuccio, MD, PhD, speaks with Claude Sirlin, MD, about his team's review on evidence-based screening strategies, quantitative imaging techniques, and emerging developments shaping the future of fibrosis assessment in…